Self-injection Device Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Self-injection Device Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The self-injection devices market is expected to register a CAGR of 6.65% over the forecast period.

The major factors boosting the growth of the self-injection devices market are the growing prevalence of chronic diseases and the benefits that lead to a rise in demand for self-injection.

Self-injection devices allow patients with chronic diseases to gain control of their treatment schedule and their treatment setting, thus allowing greater independence and freedom in their social, domestic, and professional lives. Self-injection may also offer psychological benefits over administration by healthcare professionals, including improved self-esteem. Removing the need to attend a clinic or hospital for regular injections also brings economic benefits to both the patient and the healthcare system. This economic benefit has been the major growth driving factor for this market.

Major chronic diseases such as cancer, cardiovascular diseases, chronic lung disease, stroke, Alzheimer’s, diabetes, and chronic kidney disease are on the rise all over the world, has also helped the growth as self-injections have applications in recovery from these illnesses. Cancer is a leading cause of death all around the world, accounting for around 10 million deaths in 2020. According to the GLOBOCAN 2020 report, the total number of people in the world affected by cancer in 2020 accounts to around 19,292,789 cases. The number is estimated to rise to 28,887,940 cases by 2040. ​The increasing prevalence of the chronic diseases are expected to add to the market growth, owing to the increase in drug delivery applications.

The recent product launches by major key market players are also adding to the growth of the studied market. For instance, in September 2022, Owen Mumford Pharmaceutical Services launched its new Aidaptus auto-injector platform that has a patient-centric design with automatic needle insertion that provides a simple and consistent user experience. Such activities are likely to add to the growth of the market over the forecast period.

However, stringent regulations for approval from regulatory authorities and lack of awareness of such devices in developing and underdeveloped economies have been restraining the growth of this market.

Key Market TrendsPen Injectors are Expected to Cover a Larger Market Share over the Forecast Period

Pen injectors are used for the subcutaneous delivery of biopharmaceuticals. Although they are also administered by professionals, they are primarily used for self-administration by the patient. First developed to replace vials and syringes for the treatment of diabetes with insulin, such injection devices have been an important part of drug-delivery devices for a long time.

According to the International Diabetes Federation Diabetes Atlas Tenth edition 2021, in 2021, around 537 million adults all over the world were found to have diabetes; with the numbers projected to grow to 643 million by 2030 and 783 million by 2045. Moreover, diabetes prevalence has been rising more rapidly in middle- and low-income countries. Hence, the worldwide increase in the number of diabetes cases causes an increase in the use of patient self-injection devices, which helps in the easier self-administration of insulin rather than visiting a hospital for the everyday dose. Thus, the studied market segment is expected to grow further in the future.

Owing to the rising cases of diabetes in recent years, there has been a number of product launches focused on pen injectors, that help diabetic patients administer their daily dose of insulin efficiently. For instance, in November 2021, Innovation Zed, novel diabetes management technologies developer launched the InsulCheck DOSE technology which will enter the market in 2022. Such activities are likely to add to the growth of the studied market.

North America is Expected to Dominate the Market over the Forecast Period

The North American region is expected to hold a major share of the market.

The increasing prevalence of chronic diseases in the region is a major factor contributing to the market growth over the forecast period.

The United States National Kidney Foundation 2020 has estimated that about 36 million adults in the United States have chronic kidney diseases. ​A report by the Center for Disease Control and Prevention in 2020 showed that around 15.7 million Americans are affected by chronic lower respiratory disease.​ The large population affected by chronic diseases and the increase in the necessity of self-injection systems for the ease in treatment of such diseases are expected to propel the growth of the studied market over the forecast period.​

According to the National Diabetes Statistics Report updated in January 2022, around 37.3 million people in the United States have diabetes, which equates to around 11.3% of the total population. Also, the report stated that around 96 million people aged 18 years or older in the United States have prediabetes.​ Also, as per the American Diabetes Association Statistics updated in February 2022, about 283,000 people in the United States under the age of 20 are estimated to have diagnosed diabetes, approximately 35% of that population. The large population affected by diabetes in the region is likely to add of the market growth in the region.​ Hence, with increasing prevalence of chronic diseases, the demand for self-injection devices, which are used for treatment or recovery from such diseases, are expected to increase.

The product approvals by the regulatory agencies in the region is also aiding the market growth. For instance, in December 2021, NuGen Medical Devices received approval from Health Canada for its needle-free injection system and accessories, also known as InsuJet. Such activities boost the market growth over the forecast period.

Competitive Landscape

Majority of the key player involved in research and manufacturing of self-injection devices are established in developed countries. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rising awareness.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.